Application of Medical Imaging Procedures in Surgery Implanting in Cancerology With the Aim to Reduce Invasive Acts (ATIM)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Aero digestive Cancer patients treated by external head and neck radiotherapy and/or by curie-therapy and/or mandible reconstruction by microanastomosed fibula flaps. The purpose of the study is to Investigate the accuracy of implants insertion in the anteroposterior way, using radiosurgical guidance.
| Condition | Intervention |
|---|---|
|
Upper Digestive Tract Cancer |
Procedure: Therapeutic assessment -Radio-surgical guidance. |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | Application of Medical Imaging Procedures in Surgery Implanting in Cancerology With the Aim to Reduce Invasive Acts |
- Accuracy of implants insertion, radio-surgical guidance. [ Time Frame: 8 months after inclusion ] [ Designated as safety issue: No ]
- Accuracy of inserting implants [ Time Frame: 16 months after inclusion ] [ Designated as safety issue: No ]
- Delay of mucous healing [ Time Frame: 16 months after inclusion ] [ Designated as safety issue: No ]
- Estimation of the prosthetic function [ Time Frame: 16 months after inclusion ] [ Designated as safety issue: No ]
- Osteonecrosis rate after radiation with traumatic etiology due to implantation [ Time Frame: 16 months after inclusion ] [ Designated as safety issue: No ]
- Implant rate [ Time Frame: 16 months after inclusion ] [ Designated as safety issue: No ]
- Post surgical therapeutic success after 1 year [ Time Frame: after 1 year ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 53 |
| Study Start Date: | September 2007 |
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
-
Procedure: Therapeutic assessment -Radio-surgical guidance.
The first steps of the procedure include the production of a radiosurgical guide and the preparation of a mask in order to allow precise, non invasive repositioning of the guide.
Secondarily, the patient undergoes a CT-scan with the mask on and the radiosurgical guide in place. This provisional scan is used for preimplantation evaluation and drilling of the guide hole.
Under general anaesthesia, the mask is placed on the patient and the guide is fixed to the mask. A hole is drilled with a burr in the mandible through the hole in the guide. Implants are placed and the guide and mask are removed.
A second, post-implantation CT-scan is planned 3 months after implantation. Comparison of pre- and post-implantation CT-scans allows to evaluate the precision of the placement.
- Investigate the accuracy of inserting implants in the vertical way and in angulation, on irradiated native mandible or on microanastomosed fibula flaps
- Investigate the accuracy of inserting implants in the anteroposterior way, in the vertical way and in angulation for all the involved patients (meaning on irradiated native mandible or on microanastomosed fibula flaps)
- Investigate the delay of mucous healing
- Estimate the prosthetic function
- Evaluate the osteonecrosis rate after radiation with traumatic etiology due to implantation
- Estimate the implant rate due to minimally invasive flaps
- Estimate the implant rate due to pure trans mucosa way
- Estimate the post surgical therapeutic success after 1 year
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- age over 18
- Performance status over 70
- Histological evidence of upper digestive tract cancer
- History of cranial / facial radiotherapy or brachytherapy and/or microvascular fibula transfer.
- Bone volume sufficient to support an implant.
- Mandatory affiliation with a social security system
- Written, voluntary, informed consent
Exclusion Criteria:
- Patient with evolutive malignant disease
- Contraindication to general anesthesia
- Concurrent disease contra-indicating implant surgery (risk of infectious endocarditis, uncontrolled diabetes, HIV, evolutive neoplasia…)
- Patient enrolled in another clinical trial including chemotherapy
- Pregnant or lactating woman
- Anticipation of an impossible follow-up
- Patient deprived of freedom
Contacts and Locations| France | |
| Centre Léon Bérard Service de Chirurgie-Stomatologie | |
| Lyon, Cedex 08, France, 69373 | |
| CHU Hôtel-Dieu Service d'Odontologie | |
| Clermont-ferrand, France, 63 000 | |
| Hospices Civils de Lyon Service de Consultations et Traitements Dentaires | |
| Lyon, France, 69007 | |
| Centre Hospitalier Lyon Sud Service de Stomatologie et Chirurgie Maxillo-Faciale | |
| Pierre Benite, France, 69495 | |
| Principal Investigator: | Anne-Gaëlle BODARD, MD | Centre Leon Berard |
More Information
Additional Information:
Publications:
| Responsible Party: | Centre Leon BERARD, Unité de Biostatistiques et Evaluation des Thérapeutiques |
| ClinicalTrials.gov Identifier: | NCT00925509 History of Changes |
| Other Study ID Numbers: | ET2006-032, CPP 07/033 [UBET83] |
| Study First Received: | June 2, 2009 |
| Last Updated: | June 21, 2011 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by Centre Leon Berard:
|
upper digestive tract cancer implants implants insertion radio-surgical guidance |
accuracy of implants insertion cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer. Bone volume sufficient to support an implant |
ClinicalTrials.gov processed this record on May 21, 2013